395100-11-5

Basic information

• Product Name: 4-Fluoro-3-[(4-fluorophenyl)carbonyl]benzenecarbonitrile
• Synonyms: 4-Fluoro-3-(4-fluorobenzoyl)benzonitrile;4-Fluoro-3-[(4-fluorophenyl)carbonyl]benzenecarbonitrile
• CAS NO: 395100-11-5
• Molecular Formula: C14H7F2NO
• Molecular Weight: 243.2082864
• Mol File: 395100-11-5.mol

Chemical Properties

• Appearance: /
• Density: 1.32
• CAS DataBase Reference: 4-Fluoro-3-[(4-fluorophenyl)carbonyl]benzenecarbonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Fluoro-3-[(4-fluorophenyl)carbonyl]benzenecarbonitrile(395100-11-5)
• EPA Substance Registry System: 4-Fluoro-3-[(4-fluorophenyl)carbonyl]benzenecarbonitrile(395100-11-5)

Safety Data

• Hazardous Substances Data: 395100-11-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
4-Fluoro-3-[(4-fluorophenyl)carbonyl]benzenecarbonitrile is utilized as an intermediate in the synthesis of a wide range of drugs and pharmaceuticals. Its unique structure and functional groups contribute to the development of new and innovative medications.
Used in Organic Synthesis:
As a reagent in organic synthesis, 4-Fluoro-3-[(4-fluorophenyl)carbonyl]benzenecarbonitrile plays a crucial role in the preparation of various organic compounds. Its presence of the nitrile group enhances its reactivity and makes it a key component in the synthesis process.
Used in Chemical Research:
4-Fluoro-3-[(4-fluorophenyl)carbonyl]benzenecarbonitrile is also employed in chemical research to study and understand the properties and reactions of similar compounds. Its unique structure and reactivity provide valuable insights into the development of new chemical processes and applications.

Upstream product

• 1194-02-1 4-fluorobenzonitrile 

Relevant articles and documents

Indazole compounds, compositions thereof and methods of treatment therewith

This invention is generally directed to the use of Indazole Compounds for treating or preventing diseases associated with protein kinases, including tyrosine kinases, such as proliferative diseases, inflammatory diseases, abnormal angiogenesis and diseases related thereto, atherosclerosis, macular degeneration, diabetes, obesity, pain and others. The methods comprise the administration to a patient in need thereof of an effective amount of an indazole compound that inhibits, modulates or regulates tyrosine kinase signal transduction. Novel indazole compounds or pharmaceutically acceptable salt thereof are presented herein.

Methods for treating an inflammatory condition or inhibiting JNK

This invention is generally directed to Indazole Derivatives having the following structure: 1 or pharmaceutically acceptable salt thereof, wherein R1, R2 and A are as defined herein. Such compounds have utility in the treatment of a wide range of diseases and disorders that are responsive to JNK inhibition, such as an inflammatory disease or disorder. Thus, methods of treating such diseases and disorders are also disclosed, as are pharmaceutical compositions containing one or more compounds of the above compounds.

Indazole derivatives as JNK inhibitors and compositions and methods related thereto

Compounds having activity as selective inhibitors of JNK are disclosed. The compounds of this invention are indazole derivatives having the following structure: wherein R1, R2 and A are as defined herein. Such compounds have utility in the treatment of a wide range of conditions that are responsive to JNK inhibition. Thus, methods of treating such conditions are also disclosed, as are pharmaceutical compositions containing one or more compounds of the above compounds.